(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

STIZADEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

STIZADEL

ST13

US500000079435675

Class

5

Filing

79435675

Registration

8182465

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

04/24/2026

Trademark type

Word

Nice classes

5

Filing date

09/12/2025

Registration date

03/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

04/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

CH

Examiner

CREEF, DAVIS W

Law office

N70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

20 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/23/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

GPNX

NOTIFICATION PROCESSED BY IB

01/29/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/14/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/13/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/06/2026

DOCK

ASSIGNED TO EXAMINER

12/30/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/01/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/01/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/01/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/01/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/01/2025

MAFR

APPLICATION FILING RECEIPT MAILED

11/17/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/17/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/17/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/30/2025

Continuous trademark protection

Get notified about every new filing that threatens STIZADEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.